Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC08
- Pharmacological subgroupC08C
- Chemical subgroupC08CA
- Chemical substanceC08CA08
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AIFA · 1 medicine
MS · 1 medicine · Historical list
TFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
7 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Nitrendipino | Brazil | Authorised | Aché Laboratórios Farmacêuticos S.A | ||
| Nitrendipino | Brazil | Cancelled | Biosintética Farmacêutica Ltda | ||
| Nitrencord | Brazil | Authorised | Aché Laboratórios Farmacêuticos S.A | ||
| Nitrendipina | Brazil | Cancelled | Eurofarma Laboratorios S.A. | ||
| Caltren | Brazil | Authorised | Libbs Farmacêutica Ltda | ||
| Nitrencord | Brazil | Cancelled | Biosintética Farmacêutica Ltda | ||
| Baypress | Brazil | Cancelled | Bayer S.A. |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, MS and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.